Quality assurance of patient dosimetry in boron neutron capture therapy

Acta Oncologica

Volumn 43, Issue 4, 2004, Pages 404-411

  Munck Af Rosenschöld, Per M ^a,d   Capala, Jacek ^b   Ceberg, Crister P ^a   Giusti, Valerio ^c   Salford, Leif G ^a   Persson, Bertil R R ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF PISA   (Italy)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BORON;

ARTICLE; DOSIMETRY; EVALUATION; GEOMETRY; MONTE CARLO METHOD; NEUTRON CAPTURE THERAPY; PHANTOM; PRIORITY JOURNAL; QUALITY CONTROL; TREATMENT PLANNING;

BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MONTE CARLO METHOD; PHANTOMS, IMAGING; QUALITY CONTROL; RADIATION INJURIES; RADIATION MONITORING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SENSITIVITY AND SPECIFICITY;

EID: 3042714495     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860410031390     Document Type: Article

References (38)

1. Giusti V, Munck af Rosenschöld PM, Sköld K, Montagnini B, Capala J. Monte Carlo model of the Studsvik BNCT facility: description and validation. Med Phys 2003; 30: 3107-17.
2. Capala J, H.-Stenstam B, Sköld K, Munck af Rosenschöld PM, Giusti V, Persson C, Wallin E, Brun A, Franzen L, Carlsson J, Salford LG, Ceberg C, Persson BRR, Pellettieri L, Henriksson R. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neuro-Oncol 2003; 62: 135-44.
3. Svensson H, Moller TR. Developments in radiotherapy (SBU Survey Group). Acta Oncol 2003; 42(5-6): 430-42.
4. Carlsson J, Forssell-Aronsson E, Glimelius B. Radiation therapy through activation of stable nuclides. Acta Oncol 2002; 41: 629-34.
5. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res 1999; 151: 1-18.
6. Kosunen A, Kortesniemi M, Ylä-Mella H, Seppälä T, Lampinen J, Serén T, Auterinen I, Järvinen H, Savolainen S. Twin ionization chambers for dose determinations in phantom in an epithermal neutron beam. Rad Prot Dos 1999; 81: 187-94.
7. Liu HB, Greenberg DD, Capala J, Wheeler FJ. An improved neutron collimator for brain tumor irradiations in clinical boron neutron capture therapy. Med Phys 1996; 23: 2051-60.
8. Raaijmakers CPJ, Konijnenberg MW, Verhagen HW, Mijnheer BJ. Determination of dose components in an epithermal neutron beam for boron neutron capture therapy. Med Phys 1995; 22: 321-9.
9. Rogus RD, Harling OK, Yanch JC. Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor. Med Phys 1994; 21: 1611-25.
10. Munck af Rosenschöld PM, Ceberg CP, Giusti V, Andreo P. Photon quality correction factors for ionization chambers in an epithermal neutron beam. Phys Med Biol 2002; 47: 2397-409.
11. Munck af Rosenschöld PM, Giusti V, Ceberg CP, Capala J, Sköld K, Persson BRR. Reference dosimetry at the neutron capture therapy facility at Studsvik. Med Phys 2003; 30: 1569-79.
12. Raaijmakers CPJ, Nottelman EL, Mijnheer BJ. Phantom materials for boron neutron capture therapy. Phys Med Biol 2000; 45: 2353-61.
13. Seppälä T, Vähätalo V, Auterinen I, Kosunen A, Nigg DW, Wheeler FJ, Savolainen S. Modelling of brain tissue substitutes for phantom materials in neutron capture therapy (NCT) dosimetry. Radiat Phys Chem 1999; 55: 239-46.
14. Harling OK, Roberts RA, Moulin DJ, Rogus RD. Head phantoms for boron neutron capture therapy. Med Phys 1995; 22: 579-83.
15. International Commission on Radiation Units and Measurements. Determination of absorbed dose in a patient irradiated by beams of X or gamma rays in radiotherapy procedures. ICRU Report No. 24. Bethesda, MD: ICRU Publications; 1976.
16. Kutcher GJ, Coia L, Gillin M, Hanson WF, Leibel S, Morton RJ, Palta JR, Purdy JA, Reinstein LE, Svensson GK, Weller M, Wingfield L. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys 1994; 21: 581-618.
17. Van Dam J, Marinello G. Methods for in-vivo dosimetry in external radiotherapy determination of absorbed dose in a patient irradiated by beams of X or gamma rays in radiotherapy procedures. ESTRO document, 1994, ISBN 90 5350 298 X.
18. Kobayashi T, Sakurai Y, Ishikawa M. A noninvasive dose estimation system for clinical BNCT based on PG-SPECT - conceptual study and fundamental experiments using HPGe and CdTe semiconductor detectors. Med Phys 2000; 27: 2124-32.
19. Munck af Rosenschöld PM, Verbakel WF, Ceberg CP, Stecher-Rasmussen F, Persson BRR. Toward clinical application of prompt gamma spectroscopy for in-vivo monitoring of boron uptake in boron neutron capture therapy. Med Phys 2001; 28: 787-95.
20. Verbakel WFAR. Validation of the scanning-gamma-ray telescope for in vivo dosimetry and boron measurements during BNCT. Phys Med Biol 2001; 46: 3269-85.
21. International Commission on Radiation Units and Measurements. Clinical neutron dosimetry, Part I: determination of absorbed dose in a patient treated by external beams of fast neutrons. ICRU Report No. 45. Bethesda, MD: ICRU Publications; 1989.
22. Rassow J, Stecher-Rasmussen F, Voorbraak W, Moss R, Vroegindeweij C, Hideghéty K, Sauerwien W. Comparison of quality assurance for performance and safety characteristics for boron neutron capture therapy in Petten/NL with medical electron accelerators. Rad Oncol 2001; 59: 99-108.
23. Aschan C, Serén T, Seppälä T, Benczik J, Toivonen M, Auterinen I, Savolainen S. In-vivo dosimetry of the dog irradiations at the Finnish BNCT facility. Frontiers in Neutron Capture Therapy 2001, ISBN 0 306 46442 X.
24. Seppälä T, Auterinen I, Aschan C, Serén T, Benczik J, Snellman M, Huiskamp R, Ramadan UA, Kankaranta L, Joensuu H, Savolainen S. In-vivo dosimetry of the dog irradiations at the Finnish BNCT facility. Med Phys 2002; 29: 2629-40.
25. Salford LG, Brun A, Nirfalk S. Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 1988; 69: 506-9.
26. Kiger WS III, Sakamoto S, Harling OK. Neutronic design of a fission converter-based epithermal neutron beam for neutron capture therapy. Nuc Sci Eng 1999; 131: 1-22.
27. Briesmeister JF, MCNP - a General Monte Carlo N-Particle Transport Code, Version 4C, LA-12625-M. Los Alamos, NM: Los Alamos National Laboratory; 2000.
28. 10B-paraboronophenylalanine with special reference to the evaluation of the radiation dose and damage to the normal skin. Rad Res 1994; 138: 435-42.
29. IAEA. Current status of neutron capture therapy. Technical Report Document No. 1223. Vienna: IAEA; 2000, ISSN 1011 4289.
30. Nigg DW, Wheeler FJ, Wessol DE, Capala J, Chadha M. Computational dosimetry and treatment planning for boron neutron capture therapy." J. Neuro-Oncol 1997; 33: 93-104.
31. Wessol DE, Wheeler FJ. Creating and using a type of free-form geometry in Monte Carlo Particle Transport. Nucl Sci Eng 1993; 113: 314-23.
32. Wheeler FJ, Nigg DW. Three-dimensional radiation dose distribution analysis for boron neutron capture therapy. Nucl Sci Eng 1992; 110: 16-31.
33. Elowitz EH, Bergland RM, Coderre JA, Joel DD, Chadha M, Chanana AD. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. J Neurosurg 1998; 42: 463-9.
34. Ryynanen PM, Kortesniemi M, Coderre JA, Diaz AZ, Hiismaki P, Savolainen S. Models for estimation of the (10)B concentration after BPA - fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Int J Radiat Oncol Biol Phys 2000; 48: 1145-54.
35. Brahme A, et al. Accuracy requirements and quality assurance of external beam therapy with photons and electrons. Acta Oncol 1988 (Suppl 1).
36. Mijnheer BJ, Battermann JJ, Wambersie A. What degree of accuracy is required and can be achieved in photon and neutron therapy? Radiother Oncol 1987; 8: 237-52.
37. Goorley JT, Kiger WS III, Zamenhof RG. Reference dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models. Med Phys 2000; 29: 145-56.
38. Knöös T, Johnsson SA, Ceberg CP, Tomaszewicz A, Nilsson P. Independent check of the delivered dose for high-energy X-rays using a hand-held PC. Radiother Oncol 2001; 58: 201-8.